Clinical utilities and end-user experience of pharmacogenomics: 39 mo of clinical implementation experience in an Australian hospital setting

Table 2 Number of patients (n = 56) taking medications found to have high- and/or moderate-risk drug-gene interaction against the number of such medications, in those whose medication history was available (n = 84), n (%)

Number of medications with implicated DGI	Number of patients taking medications with high-risk +/- moderate-risk DGI implicated	Number of patients taking medications with moderate-risk DGI implicated only	Number of patients taking medications with an actionable1 DGI
1	5 (6)	20 (24)	25 (30)
2	7 (8)	11 (13)	18 (21)
3	3 (4)	7 (8)	10 (12)
4	1 (1)	0 (0)	1 (1)
5	0 (0)	1 (1)	1 (1)
6	0 (0)	0 (0)	0 (0)
7	0 (0)	0 (0)	0 (0)
8	0 (0)	0 (0)	0 (0)
9	1 (1)	0 (0)	1 (1)
10	0 (0)	0 (0)	0 (0)
Total	17 (20)	39 (46)	56 (66)

¹Either high-risk drug-gene interaction (DGI) or moderate-risk DGI.

DGI: Drug-gene interaction.